首页> 外国专利> Compound for the Prevention and / or treatment of Allergy; Pharmaceutical composition, cosmetic composition, composition in the form of drink,Food and / oalimento for Pets that you understand and use of said compound and the pharmaceutical composition for the manufacture of food

Compound for the Prevention and / or treatment of Allergy; Pharmaceutical composition, cosmetic composition, composition in the form of drink,Food and / oalimento for Pets that you understand and use of said compound and the pharmaceutical composition for the manufacture of food

机译：预防和/或治疗过敏的化合物;药物组合物，化妆品组合物，饮料形式的组合物，食品和用于宠物的oalimento，您理解并使用该化合物和用于食品生产的药物组合物

页面导航

摘要
著录项
相似文献

摘要

A compound for the prevention and / or treatment of allergies, including at least a precursor of an allergen identified by an antibody isolated by a B cell or a B cell from a B cell of a nonatomic individual, but excluding an antigenAn antigen different from this allergen triggers the activity of T cells. A compound used to prevent and / or treat allergies, preferably including a nucleon sequence, which encodes two antigens of the compound as describedIt can add one or more sequences that are active in the patient's cells. This antigen from alegeno may not be recognized by T cells, and a team composed of the following major allergens can be selected: Der PL and Der PLL, pteronysinus, major antigens of home cortical dermatoses Streptococcin (SEB) and bovine betalatoglubina. The antigenic origin of the antigen that causes T cell activity may be the top of T cell antigen of tetanus toxin, diphtheria, fungus and influenza,Or the saranpi virus Alegenol's antiviral and antigenic antigens are a series of cucumbers, which are best combined and consist of a chemical connection, a pharmaceutical composition, a cosmetic composition and a beverage composition, Livestock food and / or food, including it and the compound or drug used to make the drug.

机译：用于预防和/或治疗过敏的化合物，至少包括通过由非原子个体的B细胞或B细胞从非原子个体的B细胞中分离出的抗体鉴定出的过敏原的前体，但不包括抗原过敏原触发T细胞的活性。一种用于预防和/或治疗变态反应的化合物，最好包括一个核仁序列，该序列编码所述化合物的两种抗原。它可以添加一个或多个在患者细胞中有活性的序列。来自Alegeno的这种抗原可能不会被T细胞识别，可以选择一个由以下主要过敏原组成的研究小组：Der PL和Der PLL，蕨类植物，家庭皮层皮病链球菌（SEB）的主要抗原和牛βlatogoglubina。导致T细胞活性的抗原的抗原起源可能是破伤风毒素，白喉，真菌和流感的T细胞抗原的最上层，或者沙兰皮病毒Alegenol的抗病毒和抗原性抗原是一系列黄瓜，这些黄瓜最好结合并组成化学连接，药物组合物，化妆品组合物和饮料组合物，畜禽食品和/或食品，包括它以及用于制造该药物的化合物或药物。

著录项

公开/公告号AR020102A1

专利类型
公开/公告日2002-04-10

原文格式PDF
申请/专利权人 UCB S.A.;
展开▼

申请/专利号AR1999P103185
发明设计人
展开▼

申请日1999-06-30
分类号A61K39/35;C07K14/38;C07K14/31;C07K14/435;C12N7/06;A61K7/06;A23J3/04;
国家 AR
入库时间 2022-08-22 00:46:30

相似文献

专利
外文文献
中文文献